RLAY
Relay Therapeutics Inc

1,143
Mkt Cap
$1.55B
Volume
990,258.00
52W High
$9.04
52W Low
$1.78
PE Ratio
-5.10
RLAY Fundamentals
Price
$8.57
Prev Close
$8.92
Open
$8.95
50D MA
$8.01
Beta
1.86
Avg. Volume
2.22M
EPS (Annual)
-$2.36
P/B
2.53
Rev/Employee
$38,341.00
$144.21
Loading...
Loading...
News
all
press releases
$207B Market Shift: The Race for Fast Track Approval in Oncology
$207B Market Shift: The Race for Fast Track Approval in Oncology $207B Market Shift: The Race for Fast Track Approval in Oncology PR Newswire VANCOUVER, BC, Feb. 5, 2026 Issued on behalf of...
PR Newswire·4d ago
News Placeholder
More News
News Placeholder
Relay Therapeutics (NASDAQ:RLAY) Insider Sells $11,441.30 in Stock
Relay Therapeutics, Inc. (NASDAQ:RLAY - Get Free Report) insider Peter Rahmer sold 1,354 shares of the firm's stock in a transaction dated Wednesday, January 28th. The stock was sold at an average...
MarketBeat·11d ago
News Placeholder
Insider Selling: Relay Therapeutics (NASDAQ:RLAY) CFO Sells 1,695 Shares of Stock
Relay Therapeutics, Inc. (NASDAQ:RLAY - Get Free Report) CFO Thomas Catinazzo sold 1,695 shares of Relay Therapeutics stock in a transaction dated Wednesday, January 28th. The shares were sold at an...
MarketBeat·11d ago
News Placeholder
Relay Therapeutics (NASDAQ:RLAY) Insider Donald Bergstrom Sells 2,686 Shares
Relay Therapeutics, Inc. (NASDAQ:RLAY - Get Free Report) insider Donald Bergstrom sold 2,686 shares of the firm's stock in a transaction dated Wednesday, January 28th. The shares were sold at an...
MarketBeat·11d ago
News Placeholder
Insider Selling: Relay Therapeutics (NASDAQ:RLAY) Insider Sells 11,684 Shares of Stock
Relay Therapeutics, Inc. (NASDAQ:RLAY - Get Free Report) insider Peter Rahmer sold 11,684 shares of the company's stock in a transaction on Tuesday, January 27th. The stock was sold at an average...
MarketBeat·11d ago
News Placeholder
Thomas Catinazzo Sells 13,820 Shares of Relay Therapeutics (NASDAQ:RLAY) Stock
Relay Therapeutics, Inc. (NASDAQ:RLAY - Get Free Report) CFO Thomas Catinazzo sold 13,820 shares of Relay Therapeutics stock in a transaction that occurred on Tuesday, January 27th. The stock was...
MarketBeat·11d ago
News Placeholder
Relay Therapeutics (NASDAQ:RLAY) Insider Sells 18,895 Shares
Relay Therapeutics, Inc. (NASDAQ:RLAY - Get Free Report) insider Donald Bergstrom sold 18,895 shares of Relay Therapeutics stock in a transaction dated Tuesday, January 27th. The shares were sold at...
MarketBeat·11d ago
News Placeholder
Relay Therapeutics (NASDAQ:RLAY) Stock Price Down 6.7% - Should You Sell?
Relay Therapeutics (NASDAQ:RLAY) Stock Price Down 6.7% - Here's Why...
MarketBeat·12d ago
News Placeholder
Relay Therapeutics, Inc. (NASDAQ:RLAY) Given Average Recommendation of "Moderate Buy" by Brokerages
Shares of Relay Therapeutics, Inc. (NASDAQ:RLAY - Get Free Report) have been given a consensus recommendation of "Moderate Buy" by the seven analysts that are covering the firm, MarketBeat reports...
MarketBeat·19d ago
News Placeholder
Relay Therapeutics, Inc. (NASDAQ:RLAY) Given Consensus Recommendation of "Moderate Buy" by Brokerages
Relay Therapeutics, Inc. (NASDAQ:RLAY - Get Free Report) has earned an average rating of "Moderate Buy" from the seven ratings firms that are presently covering the firm, Marketbeat Ratings reports...
MarketBeat·1mo ago
<
1
2
...
>

Latest RLAY News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.